Zivit Harpaz

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study

Salomon M. Stemmer, Ofer Benjaminov, Gal Medalia et al. · The Oncologist · 2012 · 92 citations · Full text

Medicine, Oncology, Pharmacology +16

Treatment of Dry Eye Syndrome with Orally Administered CF101

Isaac Avni, Hanna J. Garzozi, Irina S. Barequet et al. · Ophthalmology · 2010 · 83 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +11

Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.

Dimitar Gospodinov, Grisha Mateev, Gheucă Solovăstru L et al. · PubMed · 2016 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +13

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

Salomon M. Stemmer, Nebojša Manojlović, Mihai Vasile Marinca et al. · Cancers · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis

Rifaat Safadi, Marius Braun, Adi Francis et al. · Alimentary Pharmacology & Therapeutics · 2021 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11